Evaluate the Transcatheter Artificial Aortic Valve and Transcatheter Artificial Heart Values Delivery System
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 133 participants.
Also called NCT03788590
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 133 participants
- Sponsor
- Ningbo Jenscare Biotechnology Co., Ltd.
- Registry
-
NCT03788590
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT03788590. Allocation not applicable; no masking; primary purpose treatment. Start 2019-02-23 (anticipated); primary completion 2021-11-23 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluate the Transcatheter Artificial Aortic Valve and Transcatheter Artificial Heart Values Delivery System
- Acronym
- TAVI
- Condition
- Severe Aortic Stenosis
- Condition
- Aortic Regurgitation
- Intervention (Device)
- Jenscare TAVI
- Lead sponsor
- Ningbo Jenscare Biotechnology Co., Ltd.
Record details
- Record id
cardio:ct-nct03788590- Content hash
7cb10f151feb838926a60bc1a7d72cca1fb655d4aa20cb148ee7008fde5e665c